1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) Financials

AGIO

Agios Pharmaceuticals Inc
21.74
-0.24 (-1.09%)
Upgrade to Real-Time

Agios Pharmaceuticals Inc. (AGIO) Fundamentals
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
SHARE INFORMATION
Market CapUS$ 1,204,665,009
Shares Outstanding55,285,223
Float49,044,173
Percent Float88.71%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 14,240,000
Latest Fiscal EPSUS$ -4.24
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions449
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months5,335,209
Institutional Holdings Percent91.4%
Institutional Sold Previous 3 Months9,694,260
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months265,166
Insider Holdings Percent1.9
Insider Sold Previous 3 Months171,785
Insider Shares Owned1,044,583
TRADING INFO
52 Week HighUS$ 34.76
52 Week LowUS$ 16.75
52 Week High ChangeUS$ -26.68
21 Day Moving AverageUS$ 23.8929
21 Day Extended Moving AverageUS$ 24.0657
50 Day Moving AverageUS$ 26.9196
50 Day Extended Moving AverageUS$ 25.8618
200 Day Moving AverageUS$ 26.6826
200 Day Extended Moving AverageUS$ 27.8539
10 Day Average Volume614,292
20 Day Average Volume605,291
30 Day Average Volume566,374
50 Day Average Volume556,016
Alpha-0.017561
Beta0.9560
Standard Deviation0.133444
R20.148828
7 Day Price ChangeUS$ -1.84
7 Day Percent Change-7.79%
21 Day Price ChangeUS$ -3.22
21 Day Percent Change-12.87%
30 Day Price ChangeUS$ -4.73
30 Day Percent Change-17.84%
Month to Date Price ChangeUS$ -3.52
Month to Date Percent Change-13.91%
Quarter to Date Price ChangeUS$ -6.29
Quarter to Date Percent Change-22.4%
180 Day Price ChangeUS$ -7.83
180 Day Percent Change-26.43%
200 Day Price ChangeUS$ -10.06
200 Day Percent Change-31.59%
Year to Date Price ChangeUS$ -6.29
Year to Date Percent Change-22.4%

Agios Pharmaceuticals Inc. (AGIO) Key Ratios

PROFITABILITY
EBIT Margin-3,974.8%
EBITDA Margin-3,884.7%
Pre-Tax Profit Margin-353.9%
Profit Margin Count0.0%
Gross Margin88.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 14,240,000
Revenue Per ShareUS$ 0.2576
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.20
Total Debt To Equity0.10
Int Coverage-55.60
Current Ratio13.30
Leverage Ratio1.10
Quick Ratio12.50
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-5.90
Enterprise ValueUS$ 580,734,355
Price to Sales84.5973
Price to Free Cash-4.10
PE High Last 5 Years1.50
Price To Book1.20
Price To Cash Flow50.40
PE Low Last 5 Years-6.20
Price to Tangible Book1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.30
Invoice Turnover0.40
Assets Turnover0.00
Return Assets-17.87
Return on Equity-19.99
Return on Capital-28.07

Agios Pharmaceuticals Inc. (AGIO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOBrian Goff
Emplyoees393
Last AuditUQ
CIK0001439222
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address88 Sidney Street
Cambridge, MA 2139
Websitehttps://www.agios.com
Facsimile+1 617 649-8618
Telephone+1 617 649-8600
EmailHolly.Manning@agios.com
Your Recent History
NASDAQ
AGIO
Agios Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 07:14:23